Exact Mass: 406.0579

Exact Mass Matches: 406.0579

Found 199 metabolites which its exact mass value is equals to given mass value 406.0579, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Lancerin

1,3,7-trihydroxy-4-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]xanthen-9-one

C19H18O10 (406.09)

Lancerin is a C-glycosyl compound that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3, and 7 and a 1,5-anhydro-D-glucitol moiety at position 1. It has a role as a plant metabolite. It is a member of xanthones, a C-glycosyl compound and a polyphenol. Lancerin is a natural product found in Maclura cochinchinensis, Polygala tenuifolia, and other organisms with data available. A C-glycosyl compound that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3, and 7 and a 1,5-anhydro-D-glucitol moiety at position 1. Lancerin, isolated from the root bark of Cudraniu cochinchinensis, possesses anti-lipid peroxidation[1]. Lancerin, isolated from the root bark of Cudraniu cochinchinensis, possesses anti-lipid peroxidation[1].

Rotenonone

(R) -1,2-Dihydro-8,9-dimethoxy-2- (1-methylethenyl) [ 1 ] benzopyrano [ 3,4-b ] furo [ 2,3-h ] [ 1 ] benzopyran-6,12-dione

C23H18O7 (406.1052)

7-Chloro-3,4',5,6,8-pentamethoxyflavone

7-chloro-3,5,6,8-tetramethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one

C20H19ClO7 (406.0819)

7-Chloro-3,4,5,6,8-pentamethoxyflavone is found in citrus. 7-Chloro-3,4,5,6,8-pentamethoxyflavone is a constituent of a Citrus sp. (Dancy tangerine). Constituent of a Citrus species (Dancy tangerine). 7-Chloro-3,4,5,6,8-pentamethoxyflavone is found in citrus.

1-O-p-Coumaroyl-(b-D-glucose 6-O-sulfate)

[(3,4,5-Trihydroxy-6-{[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxan-2-yl)methoxy]sulphonic acid

C15H18O11S (406.057)

1-O-p-Coumaroyl-(b-D-glucose 6-O-sulfate) is found in green vegetables. 1-O-p-Coumaroyl-(b-D-glucose 6-O-sulfate) is isolated from Pteridium aquilinum (bracken fern).

Carbonyloxycamptothecin

3-ethyl-3,6,6-trihydroxy-5-oxa-9,19-diazahexacyclo[15.4.1.0^{2,7}.0^{9,21}.0^{11,20}.0^{13,18}]docosa-1(21),2(7),11(20),12,14,16,18-heptaene-4,8,22-trione

C21H14N2O7 (406.0801)

Prosulfalin

N-(dimethyl-lambda4-sulfanylidene)-4-(dipropylamino)-3,5-dinitrobenzene-1-sulfonamide

C14H22N4O6S2 (406.0981)

3-Carboxy-11-(2,4-dichlorophenyl)-3,5-dihydroxyundecanoic acid

2-[8-(2,4-dichlorophenyl)-2-hydroxyoctyl]-2-hydroxybutanedioic acid

C18H24Cl2O6 (406.095)

Glucoiberverin

(E)-[4-(methylsulfanyl)-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene]amino sulfate

C11H20NO9S3- (406.03)

Cystothiazole D

C19H22N2O4S2 (406.1021)

Antibiotic MM 27696

C14H18N2O8S2 (406.0505)

spongotine B

C20H15BrN4O (406.0429)

Neolancerin

2-c-?-d-glucopyranosyl-1,3,7-trihydroxyxanthone

C19H18O10 (406.09)

Neolancerin is a natural product found in Hypericum sampsonii and Gentiana thunbergii with data available. Neolancerin is a natural product with weak cytotoxic activity against HL-60 cells[1].

spongotine A

C20H15BrN4O (406.0429)

A member of the class of imidazolines that is 4,5-dihydro-1H-imidazole which is substituted by a 1H-indole-3-carbonyl group at position 2 and a 6-bromo-1H-indol-3-yl group at position 4S. It is a bisindole alkaloid isolated from the marine sponge, Spongosorites sp.

5,7,4,5-Tetrahydroxy-3,6,8,2-tetramethoxyflavone

C19H18O10 (406.09)

5,7,2,5-Tetrahydroxy-3,6,8,4-tetramethoxyflavone

C19H18O10 (406.09)

5,7,2,4-Tetrahydroxy-3,6,8,5-tetramethoxyflavone

C19H18O10 (406.09)

5,7,3,5-Tetrahydroxy-3,6,8,4-tetramethoxyflavone

C19H18O10 (406.09)

5,7,3,4-Tetrahydroxy-3,6,8,5-tetramethoxyflavone

C19H18O10 (406.09)

5,6,3,5-Tetrahydroxy-3,7,8,4-tetramethoxyflavone

C19H18O10 (406.09)

Hoslundin

5-Hydroxy-7-methoxy-6-ketopyranoflavone

C23H18O7 (406.1052)

2-(Benzothiazol-2-ylsulfanyl)-1-phenothiazin-10-yl-ethanone

C21H14N2OS3 (406.0268)

O1-[3-(Trifluoromethyl)benzoyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanehydroximamide

C18H13F3N4O4 (406.0889)

Oprea1_829363

C18H15ClN2O3S2 (406.0213)

1-[3-(4-Chlorophenylaminocarbonyl)benzyl]-5-(trifluoromethyl)-2-pyridone

C20H14ClF3N2O2 (406.0696)

6-Debromohamacanthin B

C20H15BrN4O (406.0429)

Acetyl-2,3,4,6-tetra-O-acetyl-5-thio-d-glucopyranoside

C16H22O10S (406.0934)

Eucleolatin

C22H14O8 (406.0689)

1-chloronephroarctin|4-Chloronephroarctin

C20H19ClO7 (406.0819)

2,9-Dibenzyl-1,8-dioxa-2,9-diaza-dispiro[3.2.3.2]dodeca-5,11-dien-3,10-dithion|2,9-dibenzyl-1,8-dioxa-2,9-diaza-dispiro[3.2.3.2]dodeca-5,11-diene-3,10-dithione

C22H18N2O2S2 (406.081)

4-chloro-5-O-methyl-3,4-deoxypsorospermin-3,5-diol

C20H19ClO7 (406.0819)

1,5-dihydroxyxanthone-6-O-beta-D-glucoside|1,5-Dihydroxyxanthone-6-O-??-D-glucoside

C19H18O10 (406.09)

3-O-beta-D-glucopyranosyl-1,6-dihydroxyxanthone

C19H18O10 (406.09)

Toddacoumaquinone

C23H18O7 (406.1052)

8-p-Hydroxybenzyldiosmetin

C23H18O7 (406.1052)

epicatechin-3-malate

C19H18O10 (406.09)

erigeroflavanone|methyl 2-[rel-(2R,3R)-3,4-dihydro-3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-2-methoxy-4-oxo-2H-chromen-3-yl]acetate|rel-(2R,3R)-3,5,7,3,4-pentahydroxy-2-methoxy-flavanone-3-acetic acid methyl ester

erigeroflavanone|methyl 2-[rel-(2R,3R)-3,4-dihydro-3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-2-methoxy-4-oxo-2H-chromen-3-yl]acetate|rel-(2R,3R)-3,5,7,3,4-pentahydroxy-2-methoxy-flavanone-3-acetic acid methyl ester

C19H18O10 (406.09)

2-(4-Hydroxyphenyl)-5,7-dihydroxy-6-[2-hydroxy-5-(hydroxycarbonyl)phenyl]-4H-1-benzopyran-4-one

C22H14O8 (406.0689)

SCHEMBL17244034

C20H15BrN4O (406.0429)

3-chloro-3,5,7,8,2-pentamethoxyflavone

C20H19ClO7 (406.0819)

6-oxo-6a,12a-dehydrodeguelin|9,10-dimethoxy-3,3-dimethyl-3H-pyrano[2,3-c;6,5-f] dichromium ene-7,13-dione|9,10-Dimethoxy-3,3-dimethyl-3H-pyrano[2,3-c;6,5-f]dichromen-7,13-dion|villosinol

C23H18O7 (406.1052)

Saliniquinone B

C23H18O7 (406.1052)

saliniquinone E

C23H18O7 (406.1052)

(14S)-saliniquinone F

C23H18O7 (406.1052)

CHEMBL1829656

C23H18O7 (406.1052)

3,4-dihydro-7-hydroxy-4-(3,4-dihydroxyphenyl)-5-[(1E)-2-(3,4-dihydroxyphenyl)ethenyl]-2H-1-benzopyran-2-one|gnetumontanin F

C23H18O7 (406.1052)

16,16-dibromohexadec-15-en-5-ynoic acid

C16H24Br2O2 (406.0143)

5-O-methylhoslundin

C23H18O7 (406.1052)

4-O-beta-D-glucopyranosyl-1,7-dihydroxyxanthone|tenuiside A

C19H18O10 (406.09)

Hypothamnolic acid

C19H18O10 (406.09)

C16H23BrO5S

C16H23BrO5S (406.0449)

7-Ac-Penioflavin

C23H18O7 (406.1052)

ACMC-20m8dm

C23H18O7 (406.1052)

Gymnocarposide

C19H18O10 (406.09)

3-O-methylhypophysciosporin

C20H19ClO7 (406.0819)

13-O-acetyl-bisanhydro-13-dihydrodaunomycinone

C23H18O7 (406.1052)

3-(1H-Indole-3-yl)-6-(6-bromo-1H-indole-3-yl)-1,2,5,6-tetrahydropyrazine-2-one

C20H15BrN4O (406.0429)

cyclographin|Cycographin

C19H15ClO8 (406.0455)

Physciosporin

C19H15ClO8 (406.0455)

3-(6-Bromo-1H-indole-3-yl)-6-(1H-indole-3-yl)-1,2,5,6-tetrahydropyrazine-2-one

C20H15BrN4O (406.0429)

Daphnodorin L

C23H18O7 (406.1052)

Aplysamine-1

C15H24Br2N2O (406.0255)

1,7-dihydroxyxanthone-3-O-beta-D-glucopyranoside|xanthohypericoside

C19H18O10 (406.09)

Val-Phe4Cl-OH

(S)-3-(4-chlorophenyl)-2-(3-isopropoxy-4-nitrobenzamido)propanoic acid

C19H19ClN2O6 (406.0932)

Phe4Cl-Val-OH

(S)-2-(3-((4-chlorobenzyl)oxy)-4-nitrobenzamido)-4-methylpentanoic acid

C19H19ClN2O6 (406.0932)

7-Chloro-3,4',5,6,8-pentamethoxyflavone

7-chloro-3,5,6,8-tetramethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one

C20H19ClO7 (406.0819)

1-O-p-Coumaroyl-(b-D-glucose 6-O-sulfate)

[(3,4,5-trihydroxy-6-{[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxan-2-yl)methoxy]sulfonic acid

C15H18O11S (406.057)

N-(5-Chloro-2-pyridinyl)-2-[(4-cyanobenzoyl)amino]-5-methoxybenzamide

C21H15ClN4O3 (406.0833)

2,4,6-Triphenylpyrylium Hydrogensulfate

C23H18O5S (406.0875)

2-(4-(8-BROMO-2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-C]QUINOLIN-1-YL)PHENYL)-2-METHYLPROPANENITRILE

C20H15BrN4O (406.0429)

[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-acetylsulfanyloxan-2-yl]methyl acetate

C16H22O10S (406.0934)

oxasulfuron

C17H18N4O6S (406.0947)

4-(Perfluorooctyl)-2-methyl-2-butanol

C11H11F13O (406.0602)

(R)-4-(2-(IODOMETHYL)-3-METHYLBUTYL)-1-METHOXY-2-(3-METHOXYPROPOXY)BENZENE

C17H27IO3 (406.1005)

(4-Fluorobenzyl)(triphenyl)phosphonium chloride

C25H21ClFP (406.1053)

Bis(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate

C16H24BF4Rh (406.0962)

Pentamethylcyclopentadienylrhenium tricarbonyl

C13H15O3Re (406.0579)

immedial brilliant green gb

C22H18N2O4S (406.0987)

3,4-Bis(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)benzamide

C20H20Cl2N2O3 (406.0851)

(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one

C16H12F6N4O2 (406.0864)

Piperazine-N,N-bis(2-hydroxypropanesulphonic acid) disodium salt

C10H20N2Na2O8S2 (406.0456)

((3,5-DICHLORO-4-(3-ISOPROPYL-4-METHOXYPHENOXY)PHENYL)ETHYNYL)TRIMETHYLSILANE

C21H24Cl2O2Si (406.0923)

lead(ii) acetylacetonate

C10H14O4Pb (406.0658)

1,1,1,2,2,3,3,4,4,5,5,6,6-Tridecafluoro-8-(propoxy)octane

C11H11F13O (406.0602)

Remoxipride hydrochloride

C16H24BrClN2O3 (406.0659)

(S)-Remoxipride ((-)-Remoxipride) hydrochloride is a selective dopamine D2-receptor antagonist with an IC50 value of 1.57 μM. (S)-Remoxipride hydrochloride can be used for the research of psychotic disorder[1].

Fosphenytoin sodium

Fosphenytoin (disodium)

C16H13N2Na2O6P (406.0307)

C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D049990 - Membrane Transport Modulators

N-[5-(diethylamino)-2-[(3,5-dinitro-2-thienyl)azo]phenyl]acetamide

C16H18N6O5S (406.1059)

9H-Fluoren-9-ylmethyl pentafluorophenyl carbonate

C21H11F5O3 (406.0628)

2,6-Diazaspiro[3.3]heptane, 2,6-bis[(4-Methylphenyl)sulfonyl]-

C19H22N2O4S2 (406.1021)

9,10-Anthracenedione,1-amino-2-bromo-4-[(4-methylphenyl)amino]-

C21H15BrN2O2 (406.0317)

D-Xylonic Acid Calcium Salt Hydrate

C10H22CaO14 (406.0635)

2,5-DIBROMO-4-(DECYLOXY)PHENOL

C16H24Br2O2 (406.0143)

CPPHA

C22H15ClN2O4 (406.072)

CPPHA is potent and selective positive allosteric modulator (PAM) of the mGluR5 and mGluR1 (metabotropic glutamate receptor). CPPHA can potentiate responses of mGluR5 and mGluR1 to activation of these receptors. CPPHA is developed for the research of central nervous system disorders[1][2].

SNG-1153

C21H17F3O5 (406.1028)

cis-2-(2,4-dichlorophenyl)-2-(1h-imidazole-1-yl)methyl-4-(methane sulfonyloxy)methyl-1,3-dioxalane

C15H16Cl2N2O5S (406.0157)

[1,1:4,1-Terphenyl]-3,3,5,5-tetracarboxylic acid

C22H14O8 (406.0689)

Pyranthrone

C30H14O2 (406.0994)

2-(4-((2-(3-Chlorophenyl)-6-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acetamide

C19H14ClF3N4O (406.0808)

Peficitinib hydrobromide

C18H23BrN4O2 (406.1004)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

Prosulfalin

C14H22N4O6S2 (406.0981)

Tyclopyrazoflor

C16H18ClF3N4OS (406.0842)

1,1-Diethyl-2,2-cyanine bromide

C23H23BrN2 (406.1044)

(-)-spongotine A

C20H15BrN4O (406.0429)

2,3-Dicarboxy-4-(2-chloro-phenyl)-1-ethyl-5-isopropoxycarbonyl-6-methyl-pyridinium

C20H21ClNO6+ (406.1057)

(2E)-3-{3-[(5-Ethyl-3-iodo-6-methyl-2-oxo-1,2-dihydropyridin-4-YL)oxy]phenyl}acrylonitrile

C17H15IN2O2 (406.0178)

(2r)-2-[(1r)-1-{[(2s)-2-Carboxy-2-(4-Hydroxyphenyl)acetyl]amino}-1-Methoxy-2-Oxoethyl]-5-Methylidene-5,6-Dihydro-2h-1,3-Oxazine-4-Carboxylic Acid

C18H18N2O9 (406.1012)

Zimeldine hydrochloride

C16H21BrCl2N2O (406.0214)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators

3-Ethyl-3,6,6-trihydroxy-5-oxa-9,19-diazahexacyclo[15.4.1.02,7.09,21.011,20.013,18]docosa-1(21),2(7),11(20),12,14,16,18-heptaene-4,8,22-trione

C21H14N2O7 (406.0801)

3-Methylthiopropylglucosinolate

C11H20NO9S3- (406.03)

3-Thiophenecarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C21H14N2O3S2 (406.0446)

2-[(3-Cyano-4-thiophen-2-yl-5,6,7,8-tetrahydroquinolin-2-yl)thio]-2-phenylacetic acid

C22H18N2O2S2 (406.081)

2-[(5Z)-5-(1-methyl-2-oxoindol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]pentanedioic acid

C17H14N2O6S2 (406.0293)

N-[2-methoxy-5-(2-oxo-1-benzopyran-3-yl)phenyl]-5-nitro-2-furancarboxamide

C21H14N2O7 (406.0801)

N-[(5-bromo-2-methoxyphenyl)methyl]-4-methyl-2,3-dihydro-1,4-benzothiazine-6-carboxamide

C18H19BrN2O2S (406.0351)

2-[(E)-{2-[(3-fluorophenyl)carbonyl]hydrazinylidene}methyl]phenyl 1,3-benzodioxole-5-carboxylate

C22H15FN2O5 (406.0965)

4-Nitrobenzoic acid [3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]methyl ester

C18H12Cl2N2O5 (406.0123)

N-[(E)-[5-(3-chloro-4-methylphenyl)furan-2-yl]methylideneamino]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide

C17H15ClN4O2S2 (406.0325)

(2S)-2-[(4S,5S)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C15H23BrN2O4S (406.0562)

(2R)-2-[(4R,5S)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C15H23BrN2O4S (406.0562)

(2S)-2-[(4R,5R)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C15H23BrN2O4S (406.0562)

(2S)-2-[(4S,5R)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C15H23BrN2O4S (406.0562)

(2R)-2-[(4R,5R)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C15H23BrN2O4S (406.0562)

(2R)-2-[(4S,5R)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C15H23BrN2O4S (406.0562)

(2S)-2-[(4R,5S)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C15H23BrN2O4S (406.0562)

1-(4-Chlorophenyl)-3-[3-(3-chlorophenyl)-1,5,5-trimethyl-2-oxoimidazolidin-4-yl]urea

C19H20Cl2N4O2 (406.0963)

2-Thiophenecarboxylic acid 4-[[5-(2-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C21H14N2O3S2 (406.0446)

(2R)-2-[(4S,5S)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C15H23BrN2O4S (406.0562)

GlcA3S(b1-4)Xyl

C11H18O14S (406.0417)

GlcA3S(b1-4)b-Xyl

C11H18O14S (406.0417)

2-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy-3-sulooxybutanedioic acid

C14H14O12S (406.0206)

[2-Hydroxy-5-[3-(4-methoxy-1-benzouran-5-yl)-3-oxopropanoyl]phenyl] hydrogen sulate

C18H14O9S (406.0359)

2-[3-[[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonooxybutanoyl]amino]propanoylamino]ethanesulfonic acid

C11H23N2O10PS (406.0811)

glucoiberverin(1-)

C11H20NO9S3 (406.03)

A thia-alkylglucosinolate resulting from the removal of the proton of the hydrogen sulfate group of glucoiberverin.

5,5',6,6',7,7'-hexahydroxy-3-methoxy-4,8'-dimethyl-1'h,3h-spiro[2-benzofuran-1,3'-[2]benzopyran]-4'-one

C19H18O10 (406.09)

methyl 5-hydroxy-3-methoxy-4-methyl-7-{2-[2-(prop-1-en-2-yl)-1,3-thiazol-4-yl]-1,3-thiazol-4-yl}hepta-2,6-dienoate

C19H22N2O4S2 (406.1021)

(5r)-3-(6-bromo-1h-indol-3-yl)-5-(1h-indol-3-yl)-5,6-dihydro-1h-pyrazin-2-one

C20H15BrN4O (406.0429)

methyl 13-chloro-15-formyl-6,14-dihydroxy-4,7,12-trimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carboxylate

C19H15ClO8 (406.0455)

2-chloro-1,3,6,8-tetrahydroxy-7-[(1s)-1-hydroxyhexyl]anthracene-9,10-dione

C20H19ClO7 (406.0819)

2-chloro-1,3,6,8-tetrahydroxy-7-(1-hydroxyhexyl)anthracene-9,10-dione

C20H19ClO7 (406.0819)

2-(4,5-dihydroxy-2-methoxyphenyl)-5,7-dihydroxy-3,6,8-trimethoxychromen-4-one

C19H18O10 (406.09)

erigeroflavanone

C19H18O10 (406.09)

(4r)-4-(3,4-dihydroxyphenyl)-5-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-7-hydroxy-3,4-dihydro-1-benzopyran-2-one

C23H18O7 (406.1052)

2-(2,4-dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-3,6,8-trimethoxychromen-4-one

C19H18O10 (406.09)

3-[2-(6-bromo-1h-indole-3-carbonyl)-4,5-dihydro-1h-imidazol-4-yl]-1h-indole

C20H15BrN4O (406.0429)

1,5-dihydroxyxanthone-6-o-β-d-glucoside

1,5-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyxanthen-9-one; 1,5-dihydroxyxanthone-6-o-beta-d-glucoside; 1,5-Dihydroxy-6-(beta-D-glucopyranosyloxy)xanthone; AC1NSUSA

C19H18O10 (406.09)

{"Ingredient_id": "HBIN001662","Ingredient_name": "1,5-dihydroxyxanthone-6-o-\u03b2-d-glucoside","Alias": "1,5-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyxanthen-9-one; 1,5-dihydroxyxanthone-6-o-beta-d-glucoside; 1,5-Dihydroxy-6-(beta-D-glucopyranosyloxy)xanthone; AC1NSUSA","Ingredient_formula": "C19H18O10","Ingredient_Smile": "C1=CC(=C2C(=C1)OC3=C(C2=O)C=CC(=C3O)OC4C(C(C(C(O4)CO)O)O)O)O","Ingredient_weight": "406.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15140;SMIT18990","TCMID_id": "25863;6183","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5316845","DrugBank_id": "NA"}

1-o-p-coumaroylglucose; beta-d-form,6-o-sulfate

C15H18O11S (406.057)

{"Ingredient_id": "HBIN002930","Ingredient_name": "1-o-p-coumaroylglucose; beta-d-form,6-o-sulfate","Alias": "NA","Ingredient_formula": "C15H18O11S","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9122","PubChem_id": "NA","DrugBank_id": "NA"}